Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection

Documenti analoghi

• LEDGF/p75 IN interaction inhibitors: in silico studies of an old target with novel approach
  di: Pant, Amit M, et al.
  Pubblicazione: (2014)
• Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
  di: Batt, Sarah M., et al.
  Pubblicazione: (2012)
• Smallest Organism; Highest Threat
  di: Pant, Amit, et al.
  Pubblicazione: (2012)
• The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis
  di: Makarov, Vadim, et al.
  Pubblicazione: (2015)
• In-silico design and evaluation of quinoline-dione derivatives as Mycobacterium tuberculosis DprE1 inhibitors
  di: Maimuna Shehu Rufa’i, et al.
  Pubblicazione: (2025-08-01)